These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12387527)

  • 1. Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers.
    Mazzantini M; Di Munno O; Metelli MR; Bulleri M; Giordani R
    Aging Clin Exp Res; 2002 Jun; 14(3):197-201. PubMed ID: 12387527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
    Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
    Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
    Hamdy NA; Papapoulos SE; Colwell A; Eastell R; Russell RG
    Bone Miner; 1993 Jul; 22(1):1-8. PubMed ID: 8219934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of bisphosphonates on new and traditional markers of bone resorption.
    Pedrazzoni M; Alfano FS; Gatti C; Fantuzzi M; Girasole G; Campanini C; Basini G; Passeri M
    Calcif Tissue Int; 1995 Jul; 57(1):25-9. PubMed ID: 7671161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate.
    Filipponi P; Cristallini S; Policani G; Casciari C; Gregorio F
    Bone; 1998 Dec; 23(6):543-8. PubMed ID: 9855463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study.
    Eggelmeijer F; Papapoulos SE; van Paassen HC; Dijkmans BA; Breedveld FC
    J Rheumatol; 1994 Nov; 21(11):2016-20. PubMed ID: 7869303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.
    Torikai E; Kageyama Y; Takahashi M; Nagano A
    Mod Rheumatol; 2006; 16(6):350-4. PubMed ID: 17164995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
    Rosen HN; Dresner-Pollak R; Moses AC; Rosenblatt M; Zeind AJ; Clemens JD; Greenspan SL
    Calcif Tissue Int; 1994 Jan; 54(1):26-9. PubMed ID: 8118749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis.
    Toussirot E; Ricard-Blum S; Dumoulin G; Cedoz JP; Wendling D
    Rheumatology (Oxford); 1999 Jan; 38(1):21-7. PubMed ID: 10334678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone.
    Kollerup G; Hansen M; Hørslev-Petersen K
    Br J Rheumatol; 1994 Sep; 33(9):816-20. PubMed ID: 8081665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
    de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
    Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis.
    Torikai E; Kageyama Y; Takahashi M; Suzuki M; Ichikawa T; Nagafusa T; Nagano A
    Rheumatology (Oxford); 2006 Jun; 45(6):761-4. PubMed ID: 16436492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of different markers of bone resorption in postmenopausal osteoporotic women treated with pamidronate.
    Kollerup G; Sørensen HA; Hyldstrup L; Storm T
    Scand J Clin Lab Invest; 1997 Oct; 57(6):479-86. PubMed ID: 9350066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritis.
    Cremers SC; Lodder MC; Den Hartigh J; Vermeij P; Van Pelt P; Lems WF; Papapoulos SE; Dijkmans BA
    J Rheumatol; 2004 Sep; 31(9):1732-7. PubMed ID: 15338492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
    Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE
    J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis.
    El Miedany YM; Abubakr IH; El Baddini M
    J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
    Terpos E; Viniou N; de la Fuente J; Meletis J; Voskaridou E; Karkantaris C; Vaiopoulos G; Palermos J; Yataganas X; Goldman JM; Rahemtulla A
    Eur J Haematol; 2003 Jan; 70(1):34-42. PubMed ID: 12631257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab.
    Ostanek L; Pawlik A; Brzosko I; Brzosko M; Sterna R; Droździk M; Gawrońska-Szklarz B
    Clin Rheumatol; 2004 Jun; 23(3):214-7. PubMed ID: 15168147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.